Please login to the form below

Not currently logged in
Email:
Password:

Scripps

This page shows the latest Scripps news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn

Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn

The Synthorx deal is his first play, and adds a technology platform that came out of the lab of Dr Floyd Romesberg of the Scripps Research Institute.

Latest news

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals during February 2014 Pharma deals during February 2014

    immunology. This deal centres around Abide's technologies (licensed from The Scripps Research Institute) to selectively target serine hydrolases, "one of the largest enzyme families involved in regulating human physiology”. The

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Shire’s Dr Armin Reininger moves to Sobi Shire’s Dr Armin Reininger moves to Sobi

    Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University in Munich, Germany, The Scripps Research Institute, and Harvard Medical School.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....
Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...

Infographics